ENTRY       D10972                      Drug
NAME        Plozalizumab (USAN/INN)
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVKPGGSLRL SCAASGFTFS AYAMNWVRQA PGKGLEWVGR IRTKNNNYAT
            YYADSVKDRF TISRDDSKNT LYLQMNSLKT EDTAVYYCTT FYGNGVWGQG TLVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELAGAPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSRDELTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            DVVMTQSPLS LPVTLGQPAS ISCKSSQSLL DSDGKTFLNW FQQRPGQSPR RLIYLVSKLD
            SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCWQGTHFP YTFGQGTRLE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H98, H144-H200, H220-L219, H226-H'226, H229-H'229, H261-H321, H367-H425, H'22-H'98, H'144-H'200, H'220-L'219, H'261-H'321, H'367-H'425, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Anti-inflammatory, Antineoplastic, C-C chemokine receptor (CCR) antagonist
  TYPE      Monoclonal antibody
COMMENT     Treatment of diabetic nephropathy and arteriovenous graft patency
TARGET      CCR2 (CD192) [HSA:729230] [KO:K04177]
  PATHWAY   hsa04060(729230)  Cytokine-cytokine receptor interaction
            hsa04062(729230)  Chemokine signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Chemokine receptors
                CCR2 (CD192)
                 D10972  Plozalizumab (USAN/INN)
DBLINKS     CAS: 1610761-46-0
            PubChem: 350078330
///
